Natco Pharma has filed a lawsuit against Novo Nordisk, asserting that it has not infringed upon any device or process technology-related patents held by the multinational company. This development ...

BioMed X & Novo Nordisk launch new collaboration in oral peptide drug delivery: Heidelberg, Germany Thursday, August 21, 2025, 12:00 Hrs [IST] BioMed X, an independent biomedical ...

Novo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company's workforce nearly doubled in five years, but slowing sales and increased ...

The pharma giant has almost doubled the size of its workforce over the last five years but is now looking to tighten cost ...

As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that almost doubled staff ...

Investing.com -- China’s Vice President Han Zheng met with Novo Nordisk (NYSE: NVO) Chairman Helge Lund in Beijing on Wednesday, according to state news agency Xinhua. During the meeting, Han stated ...

Multiple lawsuits have been filed against the makers of the popular weight-loss drug. Litigants cite blindness and other side-effects.

A federal judge has dismissed a proposed class action lawsuit accusing Novo Nordisk Inc. and its fiduciary boards of mismanaging a $1.2 billion ...

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.